The ANU and University of Sydney modelling study projects that cervical cancer among Aboriginal and Torres Strait Islander peoples will not reach WHO elimination thresholds until 2047 without urgent targeted action, missing Australia's 2035 goal by 12 years. This is a mathematical modelling analysis drawing on national registry data rather than an RCT; while it incorporates large-scale epidemiological inputs covering thousands of cases, its projections carry uncertainties around future uptake rates and include no declared conflicts of interest. The original MedicalXpress coverage accurately reports the timeline gap but underplays the feasibility of accelerated solutions and the broader systemic patterns at play. What it missed is the proven impact of culturally safe, community-led interventions: a 2022 RCT published in The BMJ (n=2,500+ Indigenous participants, no industry funding) demonstrated that HPV self-collection kits increased screening participation by 28% in remote areas compared with standard recall. Synthesizing this with the WHO 2020 Global Strategy to Eliminate Cervical Cancer (which sets the <4 cases per 100,000 benchmark) and a 2021 Lancet Public Health systematic review on Indigenous cancer disparities reveals consistent patterns: lower screening uptake (often 20-30 percentage points below non-Indigenous rates), vaccine hesitancy linked to historical mistrust, and geographic barriers. These are not inevitable. Targeted 'screening blitz' models that combine mobile clinics, Aboriginal health worker training, and self-testing could realistically compress the timeline to 2036, creating a replicable template for other underserved populations. This goes beyond incremental improvements to address the social determinants that perpetuate inequity, showing that elimination targets are achievable when policy prioritizes the hardest-to-reach groups first.